Agilent Technologies

Beyond its absolute dominance in applied chemical analysis, Agilent has aggressively and successfully expanded its profound footprint into the high-growth fields of cell analysis, genomics, and clinical pathology. Through strategic acquisitions and internal development, their advanced Dako pathology solutions and target enrichment portfolios have become widely considered the gold standard for cancer diagnostics globally.

Furthermore, Agilent distinguishes itself not just through the pristine, robust quality of its hardware, but through its highly intuitive software platforms—most notably the OpenLab suite—that seamlessly integrate massive laboratory networks, ensure strict regulatory compliance, and handle immense data processing. Driven by a deep commitment to uncompromising precision and reliability, Agilent effectively empowers scientists and clinical researchers worldwide to confidently push the boundaries of modern scientific understanding.